Dana R. Mars, NP
Nurse Practitioners (Family Nurse Practitioner)
- Medicare participating
At a glance
- Years since graduation
- 15
- In the NPI registry since
- 2012
- Medicare patients seen, 2024
- 15
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2012Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Family Nurse Practitioner primary
MA license RN2268152 -
Psychiatric/Mental Health Nurse Practitioner
MA license RN2268152
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Boston Medical Center Boston, MA
Medical groups
- Child and Family Psychological Services PLLC (278 clinicians)
- Codman Square Health Center, Inc (67 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 15
- Services billed
- 15
- Patients’ average age
- 65
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 20-29 minutes | 52 | 46 |
| Established patient office or other outpatient visit, 30-39 minutes | 11 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 3 companies reported 4 payments worth $289 in total to this clinician.
| Gilead Sciences, Inc. | $139 |
|---|---|
| Vanda Pharmaceuticals Inc. | $108 |
| Otsuka America Pharmaceutical, Inc. | $42.20 |
| Food and Beverage | $289 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.